Safety and proof of principle study of ATX-GC-59 in male and female subjects with Graves' disease not currently treated with anti-thyroid therapy: An open label study with an upward titration over 5 dose levels administered by intradermal injection - CONVERIS Research Information System by Thomson Reuters:

Go to Header Go to Navigation Go to Content Go to Footer

Title: Safety and proof of principle study of ATX-GC-59 in male and female subjects with Graves' disease not currently treated with anti-thyroid therapy: An open label study with an upward titration over 5 dose levels administered by intradermal injection

Funder
Cardiff & Vale University Health Board

Principal Investigator

Dayan, Colin

Project Details

Net value award figure for Cardiff University: £12,731.00

Start date: 01/08/2016

End date: 31/03/2020

Our policy towards the use of cookies